JP2012529423A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012529423A5 JP2012529423A5 JP2011552249A JP2011552249A JP2012529423A5 JP 2012529423 A5 JP2012529423 A5 JP 2012529423A5 JP 2011552249 A JP2011552249 A JP 2011552249A JP 2011552249 A JP2011552249 A JP 2011552249A JP 2012529423 A5 JP2012529423 A5 JP 2012529423A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- seq
- peptide
- modified
- leucine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011552249A JP5688587B2 (ja) | 2009-06-11 | 2010-06-10 | 脈絡膜新血管新生に対するワクチン療法 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009140363 | 2009-06-11 | ||
| JP2009140363 | 2009-06-11 | ||
| JP2011552249A JP5688587B2 (ja) | 2009-06-11 | 2010-06-10 | 脈絡膜新血管新生に対するワクチン療法 |
| PCT/JP2010/003871 WO2010143435A1 (en) | 2009-06-11 | 2010-06-10 | Vaccine therapy for choroidal neovascularization |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012529423A JP2012529423A (ja) | 2012-11-22 |
| JP2012529423A5 true JP2012529423A5 (enExample) | 2013-07-25 |
| JP5688587B2 JP5688587B2 (ja) | 2015-03-25 |
Family
ID=43308696
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011552249A Expired - Fee Related JP5688587B2 (ja) | 2009-06-11 | 2010-06-10 | 脈絡膜新血管新生に対するワクチン療法 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US8975229B2 (enExample) |
| EP (1) | EP2440226A4 (enExample) |
| JP (1) | JP5688587B2 (enExample) |
| KR (1) | KR20120038419A (enExample) |
| CN (1) | CN102802654A (enExample) |
| AU (1) | AU2010259797B2 (enExample) |
| BR (1) | BRPI1013025A2 (enExample) |
| CA (1) | CA2764562A1 (enExample) |
| IL (1) | IL216402A0 (enExample) |
| MX (1) | MX2011012659A (enExample) |
| RU (1) | RU2555345C2 (enExample) |
| SG (2) | SG10201403109VA (enExample) |
| TW (1) | TW201109029A (enExample) |
| WO (1) | WO2010143435A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1855707B1 (en) | 2005-02-28 | 2012-04-04 | Oncotherapy Science, Inc. | Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides |
| PL2119447T3 (pl) * | 2007-02-16 | 2013-08-30 | Oncotherapy Science Inc | Terapia szczepionkowa przeciwko neowaskularyzacji naczyniówkowej |
| FR2990352A1 (fr) | 2012-05-10 | 2013-11-15 | Univ Paris 13 | Composition immunogene comprenant un peptide derive du vegf et ses utilisations |
| JP7168228B2 (ja) * | 2017-05-19 | 2022-11-09 | 慶應義塾 | 脳神経疾患に対するペプチドワクチン及びペプチドワクチン組成物 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5861301A (en) | 1992-02-20 | 1999-01-19 | American Cayanamid Company | Recombinant kinase insert domain containing receptor and gene encoding same |
| CN1173991C (zh) | 1992-11-13 | 2004-11-03 | 马克斯普朗克科学促进协会 | 作为血管内皮生长因子受体的f1k-1 |
| WO1994021679A1 (en) | 1993-03-25 | 1994-09-29 | Merck & Co., Inc. | Inhibitor of vascular endothelial cell growth factor |
| US6100071A (en) | 1996-05-07 | 2000-08-08 | Genentech, Inc. | Receptors as novel inhibitors of vascular endothelial growth factor activity and processes for their production |
| US6080728A (en) | 1996-07-16 | 2000-06-27 | Mixson; A. James | Carrier: DNA complexes containing DNA encoding anti-angiogenic peptides and their use in gene therapy |
| DE19638745C2 (de) | 1996-09-11 | 2001-05-10 | Schering Ag | Monoklonale Antikörper gegen die extrazelluläre Domäne des menschlichen VEGF - Rezeptorproteins (KDR) |
| WO1998031794A1 (fr) | 1997-01-17 | 1998-07-23 | Toa Gosei Co., Ltd. | Polypeptide liant le facteur vegf |
| WO1998058053A1 (en) | 1997-06-18 | 1998-12-23 | Merck & Co., Inc. | Human receptor tyrosine kinase, kdr |
| WO1999040118A1 (en) | 1998-02-04 | 1999-08-12 | Kyowa Hakko Kogyo Co., Ltd. | Antibodies against human vegf receptor kdr |
| GB9804121D0 (en) | 1998-02-26 | 1998-04-22 | Cancer Res Campaign Tech | Anti-angiogenic vaccines: materials and methods relating thereto |
| EP1086705A4 (en) | 1998-05-20 | 2002-02-06 | Kyowa Hakko Kogyo Kk | INHIBITORS OF THE ACTIVITY OF THE VASCULAR ENDOTHELIAL GROWTH FACTOR |
| AU6600400A (en) | 1999-08-13 | 2001-03-13 | Crucell Holland B.V. | Methods and means for inhibiting angiogenesis |
| US7320793B2 (en) | 2001-01-19 | 2008-01-22 | Cytos Biotechnology Ag | Molecular antigen array |
| AU2002362461A1 (en) | 2001-10-01 | 2003-04-14 | Targesome, Inc. | Targeted therapeutic lipid constructs having cell surface targets |
| CU23178A1 (es) * | 2002-04-15 | 2006-09-22 | Ct Ingenieria Genetica Biotech | INMUNOTERAPIA ACTIVA ANTIANGIOGéNICA |
| DK2261249T3 (en) | 2002-09-12 | 2015-02-16 | Oncotherapy Science Inc | KDR peptides and vaccines comprising the same |
| ES2428354T3 (es) | 2002-09-18 | 2013-11-07 | Trustees Of The University Of Pennsylvania | Rapamicina para usar en la inhibición o prevención de la neovascularización coroidea |
| CN1926551B (zh) | 2003-10-27 | 2010-06-16 | 罗斯塔生化科技有限责任公司 | 用于基因沉默的siRNA的设计方法 |
| JP2006215988A (ja) * | 2005-02-07 | 2006-08-17 | Ntt Docomo Kansai Inc | 認証システム、携帯端末装置及び認証方法 |
| EP1855707B1 (en) | 2005-02-28 | 2012-04-04 | Oncotherapy Science, Inc. | Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides |
| US20060234941A1 (en) | 2005-04-15 | 2006-10-19 | The Gov. Of The Usa As Represented By The Secretary Of The Dept. Of Health & Human Services | Peptide epitopes of VEGFR-2/KDR that inhibit angiogenesis |
| JP2006315988A (ja) | 2005-05-11 | 2006-11-24 | Mototake Shimizu | ケモカイン産生誘導効果を有する血管新生阻害物質 |
| PL2119447T3 (pl) | 2007-02-16 | 2013-08-30 | Oncotherapy Science Inc | Terapia szczepionkowa przeciwko neowaskularyzacji naczyniówkowej |
| WO2008152816A1 (en) | 2007-06-14 | 2008-12-18 | Oncotherapy Science, Inc. | Methods of identifying agents that modulate methylation of vegfr1 by smyd3 |
| TWI436775B (zh) | 2007-08-24 | 2014-05-11 | Oncotherapy Science Inc | 以抗原胜肽合併化療藥劑治療胰臟癌 |
-
2010
- 2010-06-08 TW TW099118513A patent/TW201109029A/zh unknown
- 2010-06-10 SG SG10201403109VA patent/SG10201403109VA/en unknown
- 2010-06-10 SG SG2011090933A patent/SG176737A1/en unknown
- 2010-06-10 MX MX2011012659A patent/MX2011012659A/es active IP Right Grant
- 2010-06-10 CA CA2764562A patent/CA2764562A1/en not_active Abandoned
- 2010-06-10 RU RU2012100241/15A patent/RU2555345C2/ru not_active IP Right Cessation
- 2010-06-10 KR KR1020117031702A patent/KR20120038419A/ko not_active Withdrawn
- 2010-06-10 WO PCT/JP2010/003871 patent/WO2010143435A1/en not_active Ceased
- 2010-06-10 JP JP2011552249A patent/JP5688587B2/ja not_active Expired - Fee Related
- 2010-06-10 CN CN2010800356548A patent/CN102802654A/zh active Pending
- 2010-06-10 US US13/377,110 patent/US8975229B2/en not_active Expired - Fee Related
- 2010-06-10 EP EP10785967.0A patent/EP2440226A4/en not_active Withdrawn
- 2010-06-10 AU AU2010259797A patent/AU2010259797B2/en not_active Expired - Fee Related
- 2010-06-10 BR BRPI1013025A patent/BRPI1013025A2/pt not_active IP Right Cessation
-
2011
- 2011-11-17 IL IL216402A patent/IL216402A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012500001A5 (enExample) | ||
| JP6585720B2 (ja) | 眼疾患治療のペプチド及びこれを含む眼疾患治療用組成物 | |
| JP2022513223A5 (enExample) | ||
| CN105939723B (zh) | 前列腺癌治疗用组合物 | |
| JP2014521684A5 (enExample) | ||
| JP2015522576A5 (enExample) | ||
| AU2018269304B2 (en) | Preparation of biologically active complexes | |
| CN104619727A (zh) | 靶向治疗 | |
| JP2002514658A (ja) | β−アミロイド前駆体タンパク質およびユビキチンＢのフレームシフト変異体ならびにその使用 | |
| RS61230B1 (sr) | Lečenje neuroloških bolesti | |
| CN106232616A (zh) | 两亲性合成抗菌肽、其药物组合物及其用途 | |
| JP2014506450A5 (enExample) | ||
| JP2016510728A5 (enExample) | ||
| JP2015504052A5 (enExample) | ||
| JP2019535651A5 (enExample) | ||
| JP2006506942A5 (enExample) | ||
| JP2016536369A5 (enExample) | ||
| CN110945010A (zh) | 肽组合物和相关方法 | |
| HRP20140886T1 (hr) | MUTANTI CyaA POLIPEPTIDI I POLIPEPTIDNI DERIVATI PRIKLADNI ZA DOPREMANJE IMUNOGENIÄŚNIH MOLEKULA U STANICU | |
| CN120981479A (zh) | Gip/glp1/gcg三受体激动剂及其用途 | |
| RU2012100241A (ru) | Лечение хориоидальной неоваскуляризации с помощью вакцин | |
| US12552848B2 (en) | Hydrochloride salts of C5a receptor agonist peptides | |
| RU2013103487A (ru) | Вакцинотерапия неоваскуляризации сосудистой оболочки глаза | |
| JP2008531463A5 (enExample) | ||
| JP2019519466A5 (enExample) |